Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

BACKGROUND: Tumor resistance to the selective estrogen receptor modulator tamoxifen remains a serious clinical problem especially in patients with tumors that also overexpress HER2. We have recently demonstrated that the clinically important isoform of HER2, HERΔ16, promotes therapeutically refracto...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Cittelly, Diana M, Das, Partha M, Spoelstra, Nicole S, Edgerton, Susan M, Richer, Jennifer K, Thor, Ann D, Jones, Frank E
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2010
Предметы:
Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3024251/
https://ncbi.nlm.nih.gov/pubmed/21172025
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-9-317
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы